Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-021838
Filing Date
2018-04-02
Accepted
2018-04-02 17:00:54
Documents
1
Period of Report
2018-04-02

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 5261
  Complete submission text file 0001104659-18-021838.txt   6863
Mailing Address C/O TAMIR BIOTECHNOLOGY, INC. 11 DEER PARK DRIVE, SUITE 204 MONMOUTH JUNCTION NJ 08852
Business Address
BRANCACCIO JOHN P (Reporting) CIK: 0001276551 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35268 | Film No.: 18729861

Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
SYNERGY PHARMACEUTICALS, INC. (Issuer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations